M. Shinoda

Autoantibodies Against CYP2D6 and Other Drug-Metabolizing Enzymes in Autoimmune Hepatitis Type 2

Toru Usui, T. Osaka, T. Mizutani, 2005, Drug metabolism reviews.

High Levels of Autoantibodies against Drug-metabolizing Enzymes in SLA/LP-positive AIH-1 Sera

S. Matsufuji, T. Matsufuji, Y. Murakami, 2004, Autoimmunity.

Phase 3, multicentre, double-blind, randomised, parallel-group, placebo-controlled study of camostat mesilate (FOY-305) for the treatment of COVID-19 (CANDLE study)

H. Kakeya, K. Tsushima, N. Uemura, 2022, medRxiv.